BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38070099)

  • 21. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
    Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
    Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of probe-based confocal laser endomicroscopy in Lugol-unstained esophageal superficial lesions of patients with head and neck cancer.
    Safatle-Ribeiro AV; Baba ER; Faraj SF; Rios JT; de Lima MS; Martins BC; Geiger SN; Pennacchi C; Gusman C; Kawaguti FS; Uemura RS; de Melo ES; Ribeiro U; Maluf-Filho F
    Gastrointest Endosc; 2017 Jun; 85(6):1195-1207. PubMed ID: 27697445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
    Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
    Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes.
    Tajiri A; Ishihara R; Sakurai H; Nakamura T; Tani Y; Inoue T; Matsueda K; Miyake M; Waki K; Fukuda H; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Matsunaga T
    J Gastroenterol; 2022 Sep; 57(9):630-639. PubMed ID: 35788888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.
    van Tilburg L; Spaander MCW; Bruno MJ; Oudijk L; Heij LR; Doukas M; Koch AD
    Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37480179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
    Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
    J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
    Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
    Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.
    Katada C; Yokoyama T; Mure K; Doyama H; Nakanishi H; Shimizu Y; Yamamoto K; Furue Y; Tamaoki M; Koike T; Kawahara Y; Kiyokawa H; Konno M; Yokoyama A; Ohashi S; Ishikawa H; Yokoyama A; Muto M
    Jpn J Clin Oncol; 2023 Aug; 53(9):774-780. PubMed ID: 37370215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
    Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
    Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention.
    Morita M; Kumashiro R; Kubo N; Nakashima Y; Yoshida R; Yoshinaga K; Saeki H; Emi Y; Kakeji Y; Sakaguchi Y; Toh Y; Maehara Y
    Int J Clin Oncol; 2010 Apr; 15(2):126-34. PubMed ID: 20224884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma.
    Khoshbaten M; Naderpour M; Mohammadi G; Alipoor SH; Estakhri R; Fazeli Z
    Asian Pac J Cancer Prev; 2010; 11(4):863-5. PubMed ID: 21133592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
    Zhu H; Yip HC; Cheung MK; Chan HC; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Wang D; Cai L; Chan PKS; Chan JYK; Chen Z
    Int J Cancer; 2023 May; 152(9):1903-1915. PubMed ID: 36752573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does daily alcohol and/or cigarette consumption cause low-grade dysplasia, a precursor of esophageal squamous cell carcinoma?
    Kaneko K; Murakami Y; Katagiri A; Konishi K; Kubota Y; Muramoto T; Kushima M; Ohtsu A; Imawari M
    J Clin Gastroenterol; 2010 Mar; 44(3):173-9. PubMed ID: 19826274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.